1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MAXCYTE INC
MaxCyte Inc
XNAS: MXCT

MaxCyte Inc Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical ...

Read More
0.84 -0.03 (-3.45%)
69.34% Fall from 52W High
354.0K
XNAS Volume

XNAS 08 May, 2026 4:00 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for MaxCyte Inc is on 12 May 2026 for the purpose of MaxCyte Inc First Quarter Earnings Result for 2026 See details
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
27.3 / 100
Momentum Score
Technically Bearish
34.9 / 100
Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM
Analyst Price Target
4
1Yr Price target upside is 389%
4 analysts

9

S

13

W

1

O

3

T

SWOT Analysis

MaxCyte Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..